Last reviewed · How we verify
SV003
At a glance
| Generic name | SV003 |
|---|---|
| Sponsor | Shanghai Synvida Biotechnology Co.,Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants. (PHASE1)
- External Nitric Oxide Measurement Through SNO Degradation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SV003 CI brief — competitive landscape report
- SV003 updates RSS · CI watch RSS
- Shanghai Synvida Biotechnology Co.,Ltd. portfolio CI